PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Class of diabetes medication associated with lower incidence of Parkinson's disease

2015-07-21
(Press-News.org) A class of drugs used to treat diabetes may be associated with protection against Parkinson's disease (PD), according to research published this week in PLOS Medicine. The study, conducted by Dr. Ruth Brauer, of the London School of Hygiene & Tropical Medicine, found a lower incidence of PD among people using a glitazone drug (either rosiglitazone or pioglitazone) to treat diabetes when compared to people who had used different treatments for diabetes.

The cohort study was conducted using data from the UK Clinical Practice Research Datalink, and compared individuals with diabetes who were exposed to glitazones (44,597 total) with up to five individuals with diabetes who never used glitazones (120,373 in total), matched on age, sex, primary care practice, and diabetes treatment stage. The researchers analyzed the records of these patients from 1999, when glitazones were introduced to treat diabetes, until 2013. During that time, individuals who had used glitazones to treat diabetes were 28% less likely to be diagnosed with PD than individuals with diabetes who never used glitazones. Adjusting for known predictors of PD such as smoking and head injury did not alter this association. When the researchers considered past and current glitazone users separately, they found that the decreased incidence in PD was only observed in individuals currently using a glitazone (a 41% decrease in PD incidence), not those who had previously used glitazone but stopped or switched to another medication, indicating little to no persisting benefit of glitazone use.

These findings are consistent with animal and in vitro studies which suggested that glitazones and other drugs that target peroxisome proliferation-activated receptor gamma (PPARγ) may have neuroprotective effects. It is important to note that these results may not apply to people without diabetes and do not indicate whether glitazones can slow PD progression. Further, it is possible that unknown patient characteristics associated with glitazone use might also be linked to PD, contributing to the appearance of a direct causal connection. In addition, glitazones have been associated with serious side effects.

However, the authors are hopeful that these findings may pave the way towards other treatments that target the same pathway: "Our findings indicate that interventions based on the same mechanisms as PPARγ agonist activity may be fruitful targets for future research in PD."

INFORMATION:

Research Article

Funding: We received a research grant from the Michael J. Fox Foundation for Parkinson's Research. ID is funded by a Medical Research Council methodology research fellowship, KB is funded by a National Institute for Health Research postdoctoral fellowship, and LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science grant number 098504/Z/12/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: LS has received research funding from GSK and ID has consulted for, and holds stock in, GSK.

Citation: Brauer R, Bhaskaran K, Chaturvedi N, Dexter DT, Smeeth L, Douglas I (2015) Glitazone Treatment and Incidence of Parkinson's Disease among People with Diabetes: A Retrospective Cohort Study. PLoS Med 12(7): e1001854. doi:10.1371/journal.pmed.1001854

Author Affiliations: Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom Institute of Cardiovascular Sciences, University College London, London, United Kingdom Centre for Neuroinflammation & Neurodegeneration, Division of Brain Sciences, Faculty of Medicine, Imperial College, London, United Kingdom

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001854

Contact: London School of Hygiene & Tropical Medicine press office: press@lshtm.ac.uk or +44(0)207 927 2802



ELSE PRESS RELEASES FROM THIS DATE:

Diabetes drug may protect against Parkinson's disease

2015-07-21
A type of drug used to treat diabetes may reduce the risk of developing Parkinson's disease, according to a new study published in PLOS Medicine. The research, led by the London School of Hygiene & Tropical Medicine, found that diabetes patients taking glitazone antidiabetes drugs (either rosiglitazone or pioglitazone) had a 28% lower incidence of Parkinson's disease than people taking other treatments for diabetes who had never taken glitazones. [1] Glitazones are a class of drug that activate the peroxisome proliferation-activated gamma (PPARγ) receptor, which ...

Cash transfers conditional on schooling do not prevent HIV among young South African women

2015-07-21
VANCOUVER, B.C. and DURHAM, N.C. - A Phase III, individually randomized trial has found conditional cash transfers for school attendance did not reduce the risk of HIV among high-school aged women in South Africa, investigators from the HIV Prevention Trials Network (HPTN) reported today at the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver, Canada. The new finding is from HPTN 068, the first individually randomized study of young women conditioned on school attendance with an HIV incidence endpoint. In the trial, ...

New 'TripAdvisor' site to address use of substandard biomedical research tools

2015-07-21
An international panel of leading scientists is launching a new TripAdvisor-style website aimed at helping researchers choose better-quality research tools - and avoiding potentially serious errors in biomedical research. In a 'call to action' published today (Tuesday), the international expert panel warns that many scientists are unwittingly using poor-quality chemical probes, leading to mistaken conclusions being drawn from research studies. The expert panel - made up of researchers from non-profit research institutions and from biotechnology and pharmaceutical companies ...

Soybean meal positively affects pigs with PRRSV

2015-07-21
July 2, 2015 - Porcine reproductive and respiratory syndrome virus (PRRSV) is the most widespread disease in the swine industry. In sows, PRRSV causes reproductive problems during gestation, including abnormal litters or abortions. Growing pigs with the disease will have respiratory problems and poor growth. In 2012, Holtkamp and colleagues estimated the annual losses due to PRRSV to be a staggering $664 million in the U.S. alone. Producers on larger farms use vaccines and enhanced biosecurity measures to prevent eradicating an entire herd during a PRRSV outbreak. Unfortunately, ...

Specific protein as missing link for earliest known change in Alzheimer's pathology

2015-07-21
NEW YORK, July 21, 2015 -- A recent study conducted at Nathan S. Kline Institute for Psychiatric Research (NKI) and NYU Langone Medical Center implicates a new culprit in Alzheimer's disease development. The research reveals that ßCTF -- the precursor of the amyloid beta (Aß) peptide -- acts at the earliest stage of Alzheimer's to initiate a range of abnormalities leading to the loss of groups of neurons critical for memory formation. Results from the study are published online July 21, 2015 in the journal, Molecular Psychiatry, and the article has been selected ...

Acupuncture impacts same biologic pathways in rats that pain drugs target in humans

2015-07-21
WASHINGTON -- In animal models, acupuncture appears to impact the same biologic pathways ramped up by pain and stress, analogous to what drugs do in humans. Georgetown University Medical Center (GUMC) researchers say their animal study, published online in Endocrinology, provides the strongest evidence to date on the mechanism of this ancient Chinese therapy in chronic stress. "The benefits of acupuncture are well known by those who use it, but such proof is anecdotal. This research, the culmination of a number of studies, demonstrates how acupuncture might work in the ...

New treatment for severe depression with far fewer side effects

2015-07-21
Electroconvulsive therapy remains one of the most effective treatments for severe depression, but new UNSW research shows ultra-brief pulse stimulation is almost as effective as standard ECT, with far fewer cognitive side effects. The study, published today in the Journal of Clinical Psychiatry, is the first systematic review to examine the effectiveness and cognitive effects of standard ECT treatment, brief pulse stimulation, versus the newer treatment, known as ultra-brief pulse right unilateral (RUL) ECT. It comes after previous trials had shown conflicting results. ...

American History 201

American History 201
2015-07-21
Native Americans living in the Amazon bear an unexpected genetic connection to indigenous people in Australasia, suggesting a previously unknown wave of migration to the Americas thousands of years ago, a new study has found. "It's incredibly surprising," said David Reich, Harvard Medical School professor of genetics and senior author of the study. "There's a strong working model in archaeology and genetics, of which I have been a proponent, that most Native Americans today extend from a single pulse of expansion south of the ice sheets--and that's wrong. We missed something ...

The population history of Native Americans

The population history of Native Americans
2015-07-21
There is archaeological evidence of modern humans in the Americas by ca. 15 thousand years ago (KYA). However, there is still debate over exactly when and how many times the ancestors of present-day Native Americans entered the New World from Siberia. A large genome-scale study conducted by an international team headed by the Centre for GeoGenetics at the University of Copenhagen has now provided answers to these questions. The study reveals that the ancestors of all present-day Native Americans arrived in the Americas as part of a single migration wave, no earlier than ...

Location-based ads need more than closeness to overcome creepiness

2015-07-21
Location-based advertisements may pinpoint customers geographically, but often miss the target because customers may find the ads creepy and intrusive, according to an international team of researchers. To overcome this negativity, the researchers suggest advertisers invite their customers to help tailor ads they might receive. While being physically close to a product or shop improved attitudes about local advertisements on their mobile devices, customers felt significantly better about both the advertisement and location-based advertising when they had a hand in selecting ...

LAST 30 PRESS RELEASES:

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

Pinning down the process of West Nile virus transmission

UTA-backed research tackles health challenges across ages

In pancreatic cancer, a race against time

Targeting FGFR2 may prevent or delay some KRAS-mutated pancreatic cancers

[Press-News.org] Class of diabetes medication associated with lower incidence of Parkinson's disease